跳至主要内容
临床试验/ACTRN12611001286932
ACTRN12611001286932已完成未知

In patients with idiopathic interstitial pneumonia, nocturnal supplemental oxygen compared with placebo, improves sleep and quality of life

Royal Prince Alfred Hospital0 个研究点目标入组 30 人开始时间: 2011年12月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Patients 18 - 80 yrs.
  • Patients able to perform a polysomnogram (sleep study), as determined following clinical assessment.
  • Patients with nocturnal hypoxaemia, defined as >10% of the night with SpO2 <90% on overnight oximetry or PSG
  • Patients able to give informed consent.
  • Patients with idiopathic interstitial pneumonia (IIP), according to American Thoracic Society /European Respiratory Society criteria.
  • Absence of daytime resting hypoxaemia (ie with PaO2 > 55mmHg).

排除标准

  • Patients <18yrs or >80yrs.
  • Patients not able to give informed consent.
  • Patients considered unable to complete a PSG by their physician.
  • Presence of daytime resting hypoxaemia (PaO2 less than or equal to 55mmHg).
  • Presence of hypercapnia (PaCO2 > 45mmHg) at baseline
  • Patients who do not meet oxygen saturation criteria for nocturnal hypoxaemia
  • Patients with co-existent obstructive sleep apnoea with apnoea hypopnoea index greater than or equal to 15 with clinical symptoms, or apnoea hypopnoea index greater than or equal to 30 (without symptoms)
  • Patients who are current smokers

研究者

相似试验